Abstract 10454: Mechanisms of Exercise Reserve Failure in HCM and HFpEF: Differential Relationships with Myocardial Blood Flow and Fibrotic Remodeling and Limiting Symptoms
Abstract
Background: Hypertrophic cardiomyopathy (HCM) and heart failure with preserved ejection fraction (HFpEF) share exertional dyspnea, impaired cardiac-output reserve, and preserved left ventricular (LV) ejection fraction, yet the mechanism limiting exercise reserve remains poorly defined. Hypothesis: We hypothesized that exercise cardiovascular magnetic resonance (Ex-CMR) would identify distinct mechanisms limiting functional reserve in non-obstructive HCM, obstructive HCM, and HFpEF, with differential relationships to limiting symptom. Methods: In a prospective single-center, multi-referral study, consecutive patients with HCM or HFpEF and healthy controls underwent 3T Ex-CMR with paired biventricular cine imaging at rest and immediately after supine bicycle exercise as well as tissue characterization and quantitative myocardial perfusion imaging (Fig.1). Functional reserve was defined as the relative exercise-induced change in ventricular volumes and function. Symptom burden was assessed using the Kansas City Cardiomyopathy Questionnaire (KCCQ) overall summary score. Results: The study included 181 participants (57±11 years, 86 male): 40 healthy controls, 85 patients with HCM, and 56 with HFpEF. Among HCM patients, 46 had obstructive and 39 non-obstructive HCM. LV stroke-volume reserve was impaired in all patient groups compared with healthy controls: 13.5% in non-obstructive HCM, 12.0% in obstructive HCM, and 12.1% in HFpEF versus 36.1% in controls; all p<0.001. In HCM, impaired reserve was driven by failure to reduce LV end-systolic volume (ESV) during exercise, most prominently in obstructive HCM –2.8% vs. –12.5% in non-obstructive HCM vs. –18.4% in HFpEF; p<0.001) (Fig.2). A paradoxical increase in LVESV was more frequent in obstructive than non-obstructive HCM (38% vs. 11%; p=0.005; OR 5.1). In HFpEF, impaired reserve was dominated by impaired LV end-diastolic volume reserve (1.1%) compared with both HCM groups and controls (p<0.001). Tissue markers of fibrosis did not distinguish preserved from impaired reserve, whereas lower myocardial blood flow was associated with impaired reserve in HFpEF and non-obstructive HCM (Fig.3). In HCM, impaired LVESV reserve was strongly associated with worse KCCQ score (non-obstructive HCM β = –0.69 and obstructive HCM –0.68; both p<0.001), whereas exercise reserve parameters were not associated with symptoms in HFpEF (Fig.3). Conclusion: HCM and HFpEF share impaired exercise cardiac reserve but through distinct mechanisms. HCM is characterized by impaired augmentation of systolic emptying linked to symptom burden, whereas HFpEF shows exhausted preload reserve with dissociation between reserve impairment and symptoms. Fibrotic remodeling did not explain impaired reserve, while reduced myocardial perfusion emerged as a potential contributor in HFpEF and, to a lesser extent, non-obstructive HCM.